Clinical evidence suggests that the expression of SPHK1 and S1PR3 in peripheral immune cells such as leukocytes, neutrophils, monocytes, and lymphocytes are significantly elevated in the early stage of AP patients, and then reduce at the restoration stage [95,96,97]. This evidence concerns the gene SPHK1 and alkaline phosphatase measurement.